Topics:
Breast Cancer • Medical Oncology • Surgical Oncology • MD Anderson • NCI-CCC Tumor Board Question • HR+ • NCI-CCC Breast Tumor Board Question • Breast Cancer, Non-metastatic
In light of RxPonder results for postmenopausal women with early stage node positive HR+HER2- breast cancer, when is there a role for full axillary LN dissection to confirm degree of nodal involvement and when would sentinel LN evaluation be sufficient?
How would this affect adjuvant radiation plan in breast conservation therapy patients and mastectomy patients?
In RxPonder study, only 61% of patients had node d...